These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8986007)

  • 1. Effect of chronic treatment with typical and atypical neuroleptics on the expression of dopamine D2 and D3 receptors in rat brain.
    Hurley MJ; Stubbs CM; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1996 Dec; 128(4):362-70. PubMed ID: 8986007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics.
    Hurley MJ; Stubbs CM; Jenner P; Marsden CD
    Eur J Pharmacol; 1996 Dec; 318(2-3):283-93. PubMed ID: 9016916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA.
    D'Souza U; McGuffin P; Buckland PR
    Neuropharmacology; 1997; 36(11-12):1689-96. PubMed ID: 9517440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
    Damask SP; Bovenkerk KA; de la Pena G; Hoversten KM; Peters DB; Valentine AM; Meador-Woodruff JH
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):241-9. PubMed ID: 8883957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
    Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
    Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
    Reuss B; Unsicker K
    Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding.
    Svartengren J; Celander M
    Eur J Pharmacol; 1994 Mar; 254(1-2):73-81. PubMed ID: 7911431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI; Florijn WJ; Creese I
    Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of D3 dopamine receptor mRNA by neuroleptics.
    Wang W; Hahn KH; Bishop JF; Gao DQ; Jose PA; Mouradian MM
    Synapse; 1996 Jul; 23(3):232-5. PubMed ID: 8807752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors.
    Merchant KM; Figur LM; Evans DL
    Cereb Cortex; 1996; 6(4):561-70. PubMed ID: 8670682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine.
    Werme M; Ringholm A; Olson L; Brené S
    Brain Res; 2000 Apr; 863(1-2):112-9. PubMed ID: 10773199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
    Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining dopamine D3 receptor occupancy by antipsychotic drugs via [3H]7-OH-DPAT ex vivo autoradiography and its cross-validation via c-fos immunohistochemistry in the rat brain.
    Davoodi N; te Riele P; Langlois X
    Eur J Pharmacol; 2014 Oct; 740():669-75. PubMed ID: 24967534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
    Huang N; Ase AR; Hébert C; van Gelder NM; Reader TA
    Neurochem Int; 1997 Mar; 30(3):277-90. PubMed ID: 9041559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain: contrasting targets of haloperidol and clozapine.
    Guo N; Vincent SR; Fibiger HC
    Neuropsychopharmacology; 1998 Aug; 19(2):133-45. PubMed ID: 9629567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
    Mahmoudi S; Lévesque D; Blanchet PJ
    Mov Disord; 2014 Aug; 29(9):1125-33. PubMed ID: 24838395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.